Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation

L Wallentin, RD Lopes, M Hanna, L Thomas… - Circulation, 2013 - Am Heart Assoc
Background—In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced stroke and …

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.

L Wallentin, RD Lopes, M Hanna, L Thomas… - Circulation, 2013 - europepmc.org
Background In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced stroke and …

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for Stroke prevention in atrial fibrillation

L Wallentin, RD Lopes, M Hanna, L Thomas… - 2013 - dro.deakin.edu.au
Background—In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced stroke and …

Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial …

L Wallentin, RD Lopes, M Hanna, L Thomas… - …, 2013 - researchportal.helsinki.fi
Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted
International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation — University …

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for Stroke prevention in atrial fibrillation

L Wallentin, RD Lopes, M Hanna… - …, 2013 - acuresearchbank.acu.edu.au
Abstract In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial
Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced stroke and …

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for Stroke prevention in atrial fibrillation

L Wallentin, RD Lopes, M Hanna, L Thomas… - …, 2013 - research.sahmri.org.au
Background: In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced stroke and …

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation

L Wallentin, RD Lopes, M Hanna, L Thomas… - Circulation, 2013 - eprints.gla.ac.uk
Background—In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced stroke and …

[PDF][PDF] Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial …

2013 - scholar.archive.org
Background—In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced stroke and …

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation

L Wallentin, RD Lopes, M Hanna, L Thomas… - CIRCULATION, 2013 - arpi.unipi.it
Background: In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced stroke and …